You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN, Feb. 12, 2021 /PRNewswire/ -- The "Global Drug Delivery Partnering Terms and Agreements 2014-2020" report has been added to ResearchAndMarkets.com's offering. The Global Drug Delivery Partnering Terms and Agreements 2014-2020 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.This report provides details of the latest Drug Delivery agreements announced in the life sciences since 2014.The report takes the reader through a comprehensive review Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Drug Delivery partnering deals.The report presents financial deal term values for Drug Delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.One of the key highlights of the report is that over 1200 online deal records of actual Drug Delivery deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.Key benefitsGlobal Drug Delivery Partnering Terms and Agreements 2014-2020 provides the reader with the following key benefits: In-depth understanding of Drug Delivery deal trends since 2014 Access to headline, upfront, milestone and royalty data Analysis of the structure of Drug Delivery agreements with numerous real life case studies Detailed access to actual Drug Delivery contracts entered into by leading biopharma companies Identify most active Drug Delivery dealmakers since 2014 Insight into terms included in a Drug Delivery partnering agreement, with real world examples Understand the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies Available deals are listed by: Company A-Z Headline value Stage of development at signing Deal component type Specific therapy target Technology type Key Topics Covered: Executive SummaryChapter 1 - IntroductionChapter 2 - Trends in Drug Delivery dealmaking2.1. Introduction2.2. Drug Delivery partnering over the years2.3. Most active Drug Delivery dealmakers2.4. Drug Delivery partnering by deal type2.5. Drug Delivery partnering by therapy area2.6. Deal terms for Drug Delivery partnering2.6.1 Drug Delivery partnering headline values2.6.2 Drug Delivery deal upfront payments2.6.3 Drug Delivery deal milestone payments2.6.4 Drug Delivery royalty ratesChapter 3 - Leading Drug Delivery deals3.1. Introduction3.2. Top Drug Delivery deals by valueChapter 4 - Most active Drug Delivery dealmakers4.1. Introduction4.2. Most active Drug Delivery dealmakers4.3. Most active Drug Delivery partnering company profilesChapter 5 - Drug Delivery contracts dealmaking directory5.1. Introduction5.2. Drug Delivery contracts dealmaking directoryChapter 6 - Drug Delivery dealmaking by technology typeChapter 7 - Partnering resource center7.1. Online partnering7.2. Partnering events7.3. Further reading on dealmakingAppendices Appendix 1 - Drug Delivery deals by company A-Z Appendix 2 - Drug Delivery deals by stage of development Appendix 3 - Drug Delivery deals by deal type Appendix 4 - Drug Delivery deals by therapy area Appendix 5 -Deal type definitions For more information about this report visit https://www.researchandmarkets.com/r/cmlyos Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Answer: Global Drug Delivery Partnering Deals 2014-2020: Access to Headline, Upfront, Milestone and Royalty Data